JP2006500360A5 - - Google Patents

Download PDF

Info

Publication number
JP2006500360A5
JP2006500360A5 JP2004528672A JP2004528672A JP2006500360A5 JP 2006500360 A5 JP2006500360 A5 JP 2006500360A5 JP 2004528672 A JP2004528672 A JP 2004528672A JP 2004528672 A JP2004528672 A JP 2004528672A JP 2006500360 A5 JP2006500360 A5 JP 2006500360A5
Authority
JP
Japan
Prior art keywords
degrees
solvent
solution
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004528672A
Other languages
English (en)
Japanese (ja)
Other versions
JP4727990B2 (ja
JP2006500360A (ja
Filing date
Publication date
Priority claimed from GBGB0218811.8A external-priority patent/GB0218811D0/en
Application filed filed Critical
Publication of JP2006500360A publication Critical patent/JP2006500360A/ja
Publication of JP2006500360A5 publication Critical patent/JP2006500360A5/ja
Application granted granted Critical
Publication of JP4727990B2 publication Critical patent/JP4727990B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004528672A 2002-08-14 2003-08-14 モルヒネ−6−グルクロニドの塩 Expired - Fee Related JP4727990B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0218811.8A GB0218811D0 (en) 2002-08-14 2002-08-14 Salts of morphine-6-glucuronide
GB0218811.8 2002-08-14
PCT/GB2003/003562 WO2004016633A1 (en) 2002-08-14 2003-08-14 Salt of morphine-6-glucuronide

Publications (3)

Publication Number Publication Date
JP2006500360A JP2006500360A (ja) 2006-01-05
JP2006500360A5 true JP2006500360A5 (enExample) 2006-09-28
JP4727990B2 JP4727990B2 (ja) 2011-07-20

Family

ID=9942230

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004528672A Expired - Fee Related JP4727990B2 (ja) 2002-08-14 2003-08-14 モルヒネ−6−グルクロニドの塩

Country Status (17)

Country Link
US (1) US20060166900A1 (enExample)
EP (1) EP1537132B1 (enExample)
JP (1) JP4727990B2 (enExample)
KR (1) KR101077501B1 (enExample)
AT (1) ATE315041T1 (enExample)
AU (1) AU2003255790B2 (enExample)
CA (1) CA2494812C (enExample)
DE (1) DE60303149T2 (enExample)
DK (1) DK1537132T3 (enExample)
EA (1) EA008212B1 (enExample)
ES (1) ES2256790T3 (enExample)
GB (1) GB0218811D0 (enExample)
IL (1) IL166596A0 (enExample)
NO (1) NO20051261L (enExample)
PL (1) PL211031B1 (enExample)
WO (1) WO2004016633A1 (enExample)
ZA (1) ZA200501053B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ561375A (en) 2005-06-27 2011-06-30 Biovail Lab Int Srl Bupropion hydrobromide, and crystalline forms, compositions, and uses of this compound
FR2939437B1 (fr) * 2008-12-10 2010-12-17 Sanofi Aventis Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique
FR2939796B1 (fr) * 2008-12-11 2010-12-17 Sanofi Aventis Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique
CN107028968B (zh) * 2016-02-03 2020-12-04 江苏恒瑞医药股份有限公司 一种含有葡萄糖醛酸吗啡或其可药用盐的药物组合物
US20180110725A1 (en) 2016-10-21 2018-04-26 Somniferum Labs LLC Compositions, methods and kits for the safe inhaled delivery of targeted opioids for the treatment of pain and addiction
CN110054656B (zh) * 2019-05-28 2021-02-02 宜昌人福药业有限责任公司 一种10-羰基/羟基吗啡-6-葡萄糖苷酸的合成方法
CN113831373B (zh) * 2020-06-23 2023-05-16 宜昌人福药业有限责任公司 一种吗啡-6-葡萄糖苷酸脱水物杂质的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
FR2680786B1 (fr) * 1991-09-04 1995-03-10 Irepa Procede de synthese de glucuronides d'epoxy-4,5 morphinanes.
DE4403709A1 (de) * 1994-02-07 1995-08-10 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
JPH10513485A (ja) * 1995-11-29 1998-12-22 ロラボ エセ エレ オピエート性物質の糖結合体
JP2001517669A (ja) * 1997-09-25 2001-10-09 エルティエス ローマン テラピー−ズュステーメ アーゲー モルヒネアルカロイド類の酸添加塩類およびその応用
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain

Similar Documents

Publication Publication Date Title
JP2004210767A5 (enExample)
JP2005515404A5 (enExample)
NO20052058D0 (no) Behandling av influensa.
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
NO20031448L (no) Fremgangsmåte for fremstilling av nanopartikler av paclitaxel og albumin
NO20053993D0 (no) Kjemiske forbindelser.
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
NO20051503D0 (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
IS8698A (is) Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja
NO20053211D0 (no) Forbindelser for behandling av metabolske forstyrrelser.
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
JP2020109413A5 (enExample)
NO20053133D0 (no) Kjemiske forbindelser.
NO20053264D0 (no) Innretning for produksjon av honningkakehonning.
JP2006507484A5 (enExample)
NO20031648D0 (no) Farmasöytiske lösninger av modafinilforbindelser
NO20053947D0 (no) Forbedrede antitumorale behandlinger.
JP2006500360A5 (enExample)
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
EP1549106A4 (en) SPEAKER MEMBRANE AND LOUDSPEAKER USING THIS
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
ITRM20020277A0 (it) Muteine del fattore di crescita placentare tipo 1, metodo di preparazione e loro applicazioni.
IS8491A (is) Nýtt efnasamband, samsvarandi blöndur, framleiðslu- og/eða meðhöndlunaraðferðir
JP2006516021A5 (enExample)
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.